"Nov. 20, 2012 -- Although mammograms remain the gold standard for breast cancer screening, they are not the perfect test.
They don't find up to 30% of cancers, and they often find something that may be suspicious for cancer but really"...
PERJETA is contraindicated in patients with known hypersensitivity to pertuzumab or to any of its excipients.This monograph has been modified to include the generic and brand name in many instances.
Last reviewed on RxList: 6/12/2015
Additional Perjeta Information
Report Problems to the Food and Drug Administration
You are encouraged to report negative side effects of prescription drugs to the FDA. Visit the FDA MedWatch website or call 1-800-FDA-1088.
Find support and advances in treatment.